Skip to main content
Funded Studies

Maryka Quik, PhD

Senior Research Scientist at The Parkinson's Institute

Location: Sunnyvale, CA United States

Maryka Quik received her PhD in biochemistry from McGill University in Montreal, Canada. After a Medical Research Council postdoctoral fellowship at Cambridge University in England, she joined the faculty in the Department of Pharmacology at McGill University as assistant professor. She continued her career in research and teaching as a full professor in pharmacology at McGill until 1996, when she joined The Parkinson's Institute.

One line of Dr. Quik’s research is to determine the molecular basis for the very consistent epidemiological finding that there is a decreased incidence of Parkinson’s disease in smoker. The focus of her laboratory is to investigate whether nicotine may exert this apparent beneficial effect against this disorder. Studies are also in progress to investigate the molecular mechanisms that are responsible for the involuntary movements or dyskinesias that are a major complication of long-term L-dopa treatment. These combined studies may lead to the development of selective drugs for the management of Parkinson’s disease and/or as a potential strategy for long-term prevention.

Associated Grants

  • Nicotinic receptor agonists and L-dopa-induced dyskinesias


  • In Vitro Electrophysiological Studies in Experimental Models of Dyskinesias


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.